Cargando…
Omalizumab for successful chemotherapy desensitisation: What we know so far
BACKGROUND: Hypersensitivity reactions induced by chemotherapeutic drugs may influence the course of the oncologic disease by preventing doctors from prescribing first‐line therapy. In order to prevent another hypersensitivity reaction to the culprit chemotherapeutic agent, the physician can decide...
Autores principales: | Bumbacea, Roxana Silvia, Ali, Selda, Corcea, Sabina Loredana, Spiru, Luiza, Nitipir, Cornelia, Strambu, Victor, Bumbacea, Dragos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667670/ https://www.ncbi.nlm.nih.gov/pubmed/34938440 http://dx.doi.org/10.1002/clt2.12086 |
Ejemplares similares
-
Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma
por: Bumbacea, Roxana Silvia, et al.
Publicado: (2022) -
Contact Allergy Induced by Mango (Mangifera indica): A Relevant Topic?
por: Berghea, Elena Camelia, et al.
Publicado: (2021) -
Obesity and Infection: What Have We Learned From the COVID-19 Pandemic
por: Vassilopoulou, Emilia, et al.
Publicado: (2022) -
Probiotics and prebiotics in atopic dermatitis: Pros and cons (Review)
por: Fanfaret, Ionut Serban, et al.
Publicado: (2021) -
Patient and Physician Perspectives on Asthma and Its Therapy in Romania: Results of a Multicenter Survey
por: Bumbacea, Dragos, et al.
Publicado: (2021)